Two Sigma Advisers’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $690K | Sell |
|
|||||
|
2024
Q2 | $1.26M | Sell |
|
|||||
|
2024
Q1 | $1.24M | Buy |
|
|||||
|
2023
Q4 | $1.16M | Buy |
|
|||||
|
2023
Q3 | $355K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $240K | Sell |
|
|||||
|
2021
Q2 | $1.16M | Sell |
|
|||||
|
2021
Q1 | $4.66M | Buy |
|
|||||
|
2020
Q4 | $3.82M | Buy |
|
|||||
|
2020
Q3 | $641K | Buy |
|
|||||
|
2020
Q2 | $557K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $590K | Buy |
|
|||||
|
2019
Q1 | $323K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $454K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $286K | Buy |
|
|||||
|
2017
Q2 | $260K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $3.24M | Sell |
|
|||||
|
2015
Q3 | $4.47M | Buy |
|
|||||
|
2015
Q2 | $881K | Buy |
|